Sebia USA’s Post

Diagnosing hemoglobinopathies and thalassemia involves a combination of clinical evaluation, complete blood count, and hemoglobin electrophoresis. Capillary electrophoresis (CE) is increasingly recognized as a crucial confirmatory diagnostic tool due to its high resolution and sensitivity. CE separates different hemoglobin fractions based on their charge and size, allowing for precise identification of abnormal hemoglobins and quantification of variants. This technique enhances the differentiation between various types of thalassemia and hemoglobinopathies, facilitating accurate diagnosis, guiding treatment decisions, and improving patient management. Its rapid turnaround time and automation also contribute to more efficient laboratory workflows. https://lnkd.in/dH6qprPc Join this Webinar holding online on 13th November to learn more. 🤗

Compelling results of the RESCUE II Clinical Trial were recently presented during TCT 2024. Dr. Christian Bichard shared data from patients with acute intermediate-risk pulmonary embolism (PE) treated with the BASHIR™ Endovascular Catheter. Conducted at Temple University by Drs. Riyaz Bashir and Vladimir Lakhter, the study highlights the effectiveness of single-session pharmacomechanical lysis (PML) without the need for post-procedural thrombolytic infusion. #Thrombolex https://lnkd.in/eNUhhr37

In the upcoming posters I’ll share the work we did in some of the papers and hope to share valuable Evidence-based lessons: Weekly Research paper Title: The Effect of Iron Replacement Therapy on HbA1c Levels in Diabetic and Nondiabetic Patients: A Systematic Review and Meta-Analysis The amazing team: Dr Amani M. AlQarni, Dr Amal A. Alghamdi, Dr Hussain Aljubran , Dr Abdullah H. Abuzaid and Dr Mohammed A. AlYahya Questions: 1- Iron deficiency anemia (IDA) elevates Hemoglobin A1c (HbA1c) in diabetic and non-diabetic patients? Yes 2-Is the severity of IDA (lower hemoglobin) correlated with a linear increase in HbA1c? Yes 3-If we had a diabetic or an non diabetic patient and we treated them with Iron replacement therapy (IRT), will the HbA1c decrease? Yes 4-What are the routes of IRT? And if we prolonge their administration will it further decrease HbA1c? Oral and Intravenous, as far as the data shows it decreases up to 1.2% Clinical pearl: Managing IDA with IRT in diabetic patients with elevated HbA1c can help in decreasing its level and control. For further information, please check: Poster: https://lnkd.in/deyvScFm Paper: https://lnkd.in/dpAhzDPN

Excited about this upcoming webinar as 3 thought leaders share their experience operationalizing the #Quantra System.

Article Title: Navigating the Triad: Large Pericardial Effusion, Pulmonary Embolism, and CMV Seropositivity in a Challenging Clinical Scenario- A Case Report   Journal of Case Reports and Medical History (JCRMH) Acquire Publications Authors: S Zahri Abstract This case study highlights the unusual coexistence of a large pericardial effusion, pulmonary embolism, and Cytomegalovirus (CMV) seropositivity in a 52-year-old active smoker. The complex interplay between cardiovascular and infectious etiologies in this triad poses diagnostic and therapeutic challenges. Through systematic analysis, this report aims to add valuable insights to the limited literature on this complex clinical scenario. For full Article visit https://lnkd.in/gpeKguYS

New findings presented at #AAD2024 indicated that lutikizumab 300 mg every week and every other week were the most effective dosages in achieving Hidradenitis Suppurativa Clinical Response (HiSCR) 50. Dr. Alexa B. Kimball, MD, MPH, of Harvard Medical School, spoke with the HCPLive team at AAD regarding these new findings. View the discussion here: https://lnkd.in/eBHBvAt5

Stop The Bleeding Fast: Discover the latest advancements in Viscoelastic Testing. Join the upcoming webinar presented by #AABB with support from #Hemosonics. Learn about crucial concepts in blood stewardship and enhanced bleeding management. Don't miss out on this opportunity to delve into #patientbloodmanagement.

Today at #EHA2024, clinical data from the Phase 1/2 EdiTHAL trial of reni-cel in patients with transfusion-dependent beta thalassemia will be presented in a poster presentation. Learn more: http://bit.ly/3WBoV0T #EHA2024 #geneediting #thalassemia

𝐇𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 𝐂: 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐮𝐫𝐞 🔬Breakthrough Antiviral Meds: Direct-acting antivirals (DAAs) have revolutionized HCV treatment, boasting up to 99% cure rates! 💡Personalized Therapies: Tailoring treatment plans based on HCV genotype and patient factors maximizes efficacy and minimizes side effects. 📉Shorter Duration: Modern regimens often require just 8-12 weeks of therapy, significantly reducing treatment time compared to older methods. 🛡️Early Detection is Key: Advances in screening techniques allow for early diagnosis, improving outcomes and preventing liver complications. Boost your research potential with https://www.sciqst.com, your go-to tool for quick, comprehensive biomedical literature reviews! 📚✨ #HepatitisC #MedicalResearch #HealthcareInnovation

Discover key insights on septic shock management, including challenges in early identification, the role of biomarkers, and limitations of screening tools like SIRS and qSOFA. Explore evidence-based resuscitation strategies, including fluid resuscitation, vasopressor use, and lactate monitoring to guide treatment and improve patient outcomes. Full article:  https://lnkd.in/dSnw8_FG Emergency medicine simplified. #SepticShockManagement #EpicEM #EmergencyMedicine